MGRC expands presence in Thailand

KUALA LUMPUR: Malaysian Genome Resource Center Bhd (MGRC) has signed a series of collaborations to grow its customer base in Thailand, as well as to explore research and development (R&D) opportunities for new products and services.

In a filing with Bursa Malaysia, the genomics and biopharma specialist said it has signed a supply and collaboration agreement with Acquest Healthcare Stem Cell Research and Development Co Ltd to produce CAR T cells for supply to Acquest customers.

It has also signed a supply and collaboration agreement with Salus Holdings Co Ltd to provide biopharmaceutical and genomics products and services to Salus customers.

Salus is a wellness and health screening specialist using science and technology for early disease detection and program management to

lifestyle intervention based in Bangkok, Thailand.

Finally, the group signed a letter of intent with Marine Group Co Ltd and Salus on collaborative research in the use of genetic screening tests and formulated cosmetic products containing certain cell therapy ingredients on the regeneration of skin and patient hair.

“We look forward to a fruitful relationship with our Thai partners, Salus and Acquest. These collaborations are part of our strategy to grow our customer base and increase our overseas presence by working with business partners who have an established presence in their respective market segments,” said Sasha Nordin, Managing Director of MGRC.


Leave a Comment